These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3542535)

  • 1. The effects of acebutolol alone and in combination with furosemide or hydralazine in experimentally induced hypertensive G-minipigs.
    Yasuda Y; Hidaka H; Sawada S; Tanioka Y
    Jikken Dobutsu; 1986 Oct; 35(4):367-73. PubMed ID: 3542535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single administration of captopril and combined use with beta-blocker and/or thiazide diuretic in the treatment of essential hypertension.
    Yoneda S; Kako T; Koketsu M; Hayano J; Asakawa T; Fujinami T; Kato T
    Angiology; 1991 Nov; 42(11):914-23. PubMed ID: 1683186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merits of adding a beta blocker (acebutolol) to a diuretic (hydrochlorothiazide) in the treatment of hypertension.
    Belleau LJ; Lebel M; Brossard JJ
    J Clin Pharmacol; 1982 Jan; 22(1):20-7. PubMed ID: 7037871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the acute effects of acebutolol and propranolol on blood pressure, heart rate and hormonal changes during graded treadmill exercise in patients with essential hypertension.
    Matsuura H; Masaoka S; Kanazawa I; Murano S; Tsuchioka Y; Kajiyama G
    Jpn J Med; 1989; 28(1):8-15. PubMed ID: 2657144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension.
    Thibonnier M; Lardoux MD; Corvol P
    Br J Clin Pharmacol; 1980 Jun; 9(6):561-7. PubMed ID: 6992823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of idiopathic hyperaldosteronism with normal plasma aldosterone concentrations for 5 years after onset: a 12-year follow-up study].
    Nemoto T; Niimura S; Hayashi A; Gomibuchi T; Sanada H; Watanabe Y; Shigetomi S; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1994 May; 70(4):439-46. PubMed ID: 7958093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
    Siitonen L
    J Int Med Res; 1980; 8(3):181-7. PubMed ID: 6993250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker).
    Menard J; Bertagna X; N'Guyen PT; Degoulet P; Corvol P
    Am J Med; 1976 May; 60(6):886-90. PubMed ID: 14503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid identification of diabetic patients with essential hypertension sensitive to acebutolol.
    Passa P; Tugaye A; Gauville C; Canivet J
    Diabete Metab; 1981 Sep; 7(3):155-9. PubMed ID: 7033007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of angiotensin II antagonist, Sar1-Ile8-angiotensin II, on furosemide-induced increase in plasma noradrenaline, renin activity and aldosterone in unanesthetized dogs.
    Ueno Y; Arita M; Suruda H; Ohtani H; Minakata T; Kuchii M; Nishio I; Masuyama Y
    Jpn Circ J; 1980 Dec; 44(12):981-7. PubMed ID: 7003179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma renin activity and aldosterone concentration are not altered by the novel calcium channel antagonist, azelnidipine, in hypertensive patients.
    Kondo T; Goto R; Sonoda K; Yasuda T; Ono K; Takaki Y; Yatsuda R; Miyamura N; Araki E
    Intern Med; 2010; 49(7):637-43. PubMed ID: 20371952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic significance of dosing intervals in beta receptor blocking therapy of hypertension with acebutolol.
    Frick MH; Kala R
    Am J Cardiol; 1981 Nov; 48(5):911-6. PubMed ID: 6118059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of acebutolol to diuretics in hypertension.
    Gorkin JU; Elijovich F; Dziedzic SW; Krakoff LR
    Clin Pharmacol Ther; 1981 Dec; 30(6):739-44. PubMed ID: 6118215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
    Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
    Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y
    Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.
    Witzgall H; Thayil G; Weber PC
    Klin Wochenschr; 1982 Aug; 60(16):847-52. PubMed ID: 6752560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acebutolol test in moderate arterial hypertension. Action on systolic time intervals].
    Ducrocq MB; Degoulet P; Charpentier A; Corvol P; Ménard J
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3268-72. PubMed ID: 768908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
    Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
    Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.